Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
about
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.Emerging strategies and therapies for treatment of Paget's disease of bone.Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of boneAn assessment of the ability of human bone marrow cultures to generate osteoclasts.Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling.Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's diseaseUse of zoledronic acid in the treatment of Paget's disease.Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironmentEnhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.Epidemiology and pathology of Paget's disease of bone - a review.Dickkopf-1 as a potential therapeutic target in Paget's disease of bone.Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene.The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
P2860
Q33939814-757893EA-9FA9-4BB7-A5AE-4992F835B376Q34512953-88E70B1E-84B9-4DE6-A3D0-EB63AA5953F2Q34987305-CA143FEF-DBE5-4688-9860-D1246E156233Q35230624-F3C39E95-640C-4465-8803-9E56321B7FD1Q35595884-44B50E53-D501-4EFB-BFB4-379AE120E4E3Q36029382-219D12D8-8C02-4D95-813A-B9CEECCC42C0Q36553375-46AD2800-4897-4D0A-A91F-4B03440697DBQ36618526-2C3436A2-5491-450D-9777-5492DA9C6552Q36645767-AB66A007-8D84-468D-A655-0A2B30D41B32Q36874731-6EBB1570-EBDC-4D1B-8EEF-B898716EB573Q36967966-5584945E-E38E-4EFC-A595-BAF832EA9C04Q37202226-07952D6E-1A82-4C40-BF53-B6FAE161AFAEQ37578050-8659F17A-DE07-4FE0-A768-48121ED41ABBQ37607309-B3D0B368-5E56-4E66-AC30-F6ADC9D1C0D0Q37670256-EBFEC6BB-50C3-45FD-9D59-8E28CEE43640Q38013655-4F8FB3C2-99E9-4498-86AA-A30021C8AA6CQ41220165-339D28EB-FF3B-4D32-9EF6-EF15C748934DQ41877603-6300DC0F-EB21-4901-BD1E-6E28872D8365
P2860
Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
name
Atypical multinucleated cells ...... patients with Paget's disease.
@ast
Atypical multinucleated cells ...... patients with Paget's disease.
@en
Atypical multinucleated cells ...... patients with Paget's disease.
@nl
type
label
Atypical multinucleated cells ...... patients with Paget's disease.
@ast
Atypical multinucleated cells ...... patients with Paget's disease.
@en
Atypical multinucleated cells ...... patients with Paget's disease.
@nl
prefLabel
Atypical multinucleated cells ...... patients with Paget's disease.
@ast
Atypical multinucleated cells ...... patients with Paget's disease.
@en
Atypical multinucleated cells ...... patients with Paget's disease.
@nl
P2093
P2860
P356
P1476
Atypical multinucleated cells ...... patients with Paget's disease.
@en
P2093
P2860
P304
P356
10.1172/JCI114565
P407
P577
1990-04-01T00:00:00Z